Evidence map›Paper›PMID 28095138›Full record

ReviewOphthalmic genetics

Leber congenital amaurosis, from darkness to light: An ode to Irene Maumenee.

Razek Georges Coussa, Irma Lopez Solache, Robert K Koenekoop

Open access · greenAbstract readBiographyHistorical ArticleReview
In one paragraph

Review in Ophthalmic genetics. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 28 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Razek Georges Coussaa Department of Paediatric Surgery, Montreal Children's Hospital , McGill University Health Centre , Montreal , Quebec , Canada.
Irma Lopez Solacheb The McGill Ocular Genetics Laboratory, Paediatric Ophthalmology Division , Montreal Children's Hospital, McGill University Health Centre , Montreal , Quebec , Canada.
Robert K Koenekoopa Department of Paediatric Surgery, Montreal Children's Hospital , McGill University Health Centre , Montreal , Quebec , Canada.
McGill University Health Centre · CA

Funding

GENETICS OF EARLY ONSET RETINAL DISEASESR01EY018571 · NEI · UNIVERSITY OF CALIFORNIA-IRVINE · PI RUI CHEN · 2008 to 2026
$7.2M
CIHRNEI NIH HHS R01 EY018571
6 · The paper itself

Abstract

This article is dedicated to Irene Hussels Maumenee, Professor of Human Genetics and Ophthalmology, Johns Hopkins' Wilmer Eye Institute, Ocular Genetics Fellowship director in 1994-1995. Leber congenital amaurosis (LCA) has almost come full circle, from a profound and molecularly uncharacterized form of congenital retinal blindness to one in which a large number of causative genes and disease pathways are known, and the world's first human retinal disease to be treated by gene therapy. Dr. Maumenee's insights, efforts, and leadership have contributed significantly to this remarkable scientific journey. In this manuscript, we present a short summary of the known LCA genes, LCA disease subtypes, and emerging treatment options. Our manuscript consolidates previous knowledge with current findings in an attempt to provide a more comprehensive understanding of LCA.

Indexed as

Eye ProteinsGenetic TherapyHistory, 20th CenturyHistory, 21st CenturyHumansLeber Congenital AmaurosisMutationEye ProteinsCausal genesdisease subtypesemerging treatment optionsLeber congenital amaurosis (LCA)

Identifiers

PMID28095138
PMCPMC5607866
OpenAlexW2571663776

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.